D. Yavagal

Progress in Intra-Arterial Stem Cell Therapy for Ischemic Stroke: A Review

Stroke kills almost 130 000 Americans each year—that is 1 in every 18 deaths. Until 2015, intravenous thrombolysis was the only approved acute reperfusion therapy available but has several limitations in its application. The last decade has witnessed tremendous advances in acute ischemic stroke therapy, particularly wi...